Cyclophosphamide and Bleeding into the skin - a phase IV clinical study of FDA data
Bleeding into the skin is found among people who take Cyclophosphamide, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Cyclophosphamide and have Bleeding into the skin. It is created by eHealthMe based on reports of 149,447 people who have side effects when taking Cyclophosphamide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
149,447 people reported to have side effects when taking Cyclophosphamide.
Among them, 172 people (0.12%) have Bleeding into the skin.
What is Cyclophosphamide?
Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 149,590 Cyclophosphamide users for its effectiveness, alternative drugs and more.
What is Bleeding into the skin?
Bleeding into the skin is found to be associated with 2,173 drugs and 1,718 conditions by eHealthMe.
Number of Cyclophosphamide and Bleeding into the skin reports submitted per year:
Time on Cyclophosphamide when people have Bleeding into the skin *:
Gender of people who have Bleeding into the skin when taking Cyclophosphamide*:
Age of people who have Bleeding into the skin when taking Cyclophosphamide *:
Common drugs people take besides Cyclophosphamide *:
Common side effects people have besides Bleeding into the skin *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Cyclophosphamide and have Bleeding into the skin?Check whether Bleeding into the skin is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
How severe was Bleeding into the skin and when was it recovered:
Expand to all the drugs that have ingredients of cyclophosphamide:
Alternative drugs to, pros and cons of Cyclophosphamide:
- Cyclophosphamide (149,590 reports)
Common Cyclophosphamide side effects:
Browse all side effects of Cyclophosphamide:a b c d e f g h i j k l m n o p q r s t u v w x y z
Bleeding into the skin treatments and more:
- Bleeding into the skin (13,575 reports)
COVID vaccines that are related to Bleeding into the skin:
- Bleeding into the skin in Moderna COVID Vaccine
- Bleeding into the skin in Pfizer BioNTech Covid Vaccine
- Bleeding into the skin in Johnson and Johnson Covid Vaccine
Common drugs associated with Bleeding into the skin:
All the drugs that are associated with Bleeding into the skin:
- Bleeding into the skin (2,173 drugs)
Common conditions associated with Bleeding into the skin:
All the conditions that are associated with Bleeding into the skin:
- Bleeding into the skin (1,718 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on cyclophosphamide (the active ingredients of Cyclophosphamide) and Cyclophosphamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Beyaz vs. Previfem - 2 seconds ago
- Aleve and Dysphoria - 3 seconds ago
- Asacol and Injection Site Bruising - 11 seconds ago
- Acetylcysteine and Muscle Spasms - 11 seconds ago
- Moxifloxacin and Insomnia - 14 seconds ago
- Methionine and Urinary Tract Infection - 16 seconds ago
- Pemetrexed and Deep Venous Thrombosis - 19 seconds ago
- Epiduo and Hyperthyroidism - 21 seconds ago
- Amoxicillin And Clavulanate Potassium and Solifenacin Succinate drug interaction - 21 seconds ago
- Flomax and Irritable Bowel Syndrome - 22 seconds ago